Great Lakes Advisors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-172,337
Closed -$7.05M 911
2024
Q2
$7.05M Sell
172,337
-160,984
-48% -$6.58M 0.06% 244
2024
Q1
$14.1M Buy
+333,321
New +$14.1M 0.12% 168